Inotiv Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Inotiv şirketinin toplam hissedar öz sermayesi $182.1M ve toplam borcu $382.4M olup, bu da borç-öz sermaye oranını 210% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $774.6M ve $592.5M dir.

Anahtar bilgiler

210.0%

Borç/özkaynak oranı

US$382.45m

Borç

Faiz karşılama oranı	n/a
Nakit	US$14.43m
Eşitlik	US$182.11m
Toplam yükümlülükler	US$592.48m
Toplam varlıklar	US$774.59m

Son finansal sağlık güncellemeleri

Recent updates

Inotiv, Inc.'s (NASDAQ:NOTV) 57% Dip In Price Shows Sentiment Is Matching Revenues

Apr 26

Inotiv (NASDAQ:NOTV) Takes On Some Risk With Its Use Of Debt

Mar 19

Inotiv, Inc.'s (NASDAQ:NOTV) Price Is Right But Growth Is Lacking After Shares Rocket 34%

Feb 13

Inotiv, Inc. (NASDAQ:NOTV) Stock Rockets 61% But Many Are Still Ignoring The Company

Dec 18

Earnings Release: Here's Why Analysts Cut Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$12.81

Dec 13

Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Nov 21

Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Aug 14

Is Inotiv (NASDAQ:NOTV) Using Debt In A Risky Way?

May 09

Inotiv adds 16% on settlement with U.S. over Virginia facility

Jul 18

Inotiv completes acquisition of bioanalytical company Protypia for ~$11M

Jul 07

Headwaters Capital - Inotiv: Transformation Into A Critical Full-Service Contract Research Organization

May 25

Inotiv: Leading Mid-Market CRO Ups Its Game

Feb 07

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: NOTV 'nin kısa vadeli varlıkları ( $149.2M ) kısa vadeli yükümlülüklerini ( $485.1M ) kapsamıyor.

Uzun Vadeli Yükümlülükler: NOTV şirketinin kısa vadeli varlıkları ( $149.2M ) uzun vadeli yükümlülüklerini ( $107.4M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: NOTV 'nin net borç/öz sermaye oranı ( 202.1% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: NOTV şirketinin borç/öz sermaye oranı son 5 yılda 138.8% seviyesinden 210% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: NOTV şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: NOTV tarihsel oranlara göre serbest nakit akışı büyümeye veya küçülmeye devam ederse yeterli nakit pistine sahip olup olmadığını belirlemek için yeterli veri yok.

Inotiv Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Inotiv, Inc. announced delayed 10-Q filing

Inotiv (NASDAQ:NOTV) Takes On Some Risk With Its Use Of Debt

Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Is Inotiv (NASDAQ:NOTV) Using Debt In A Risky Way?

Inotiv, Inc. announced delayed annual 10-K filing

Recent updates

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Inotiv, Inc. has filed a Follow-on Equity Offering in the amount of $50 million.

Inotiv, Inc. has filed a Follow-on Equity Offering in the amount of $50 million.

Price target decreased by 70% to US$4.67

Inotiv, Inc. to Report Q3, 2024 Results on Aug 08, 2024

Inotiv, Inc. Withdraws Financial Guidance for Fiscal Year 2024

Inotiv, Inc. announced delayed 10-Q filing

Inotiv, Inc. to Report Q2, 2024 Results on May 10, 2024

Inotiv, Inc.'s (NASDAQ:NOTV) 57% Dip In Price Shows Sentiment Is Matching Revenues

New major risk - Share price stability

Inotiv (NASDAQ:NOTV) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates upgraded to US$1.15 loss

Inotiv, Inc.'s (NASDAQ:NOTV) Price Is Right But Growth Is Lacking After Shares Rocket 34%

Price target increased by 22% to US$15.50

An unknown buyer acquired RMS facilities in Spain and France from Inotiv, Inc. (NasdaqCM:NOTV).

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Inotiv, Inc. Reaffirms Earnings Guidance for the Fiscal 2024

Inotiv, Inc. to Report Q1, 2024 Results on Feb 07, 2024

Inotiv, Inc., Annual General Meeting, Mar 14, 2024

Consensus EPS estimates fall by 18%

Inotiv, Inc. (NASDAQ:NOTV) Stock Rockets 61% But Many Are Still Ignoring The Company

Chief Operating Officer recently bought US$150k worth of stock

Earnings Release: Here's Why Analysts Cut Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$12.81

Full year 2023 earnings: EPS misses analyst expectations

Inotiv, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Inotiv, Inc. to Report Q4, 2023 Results on Dec 11, 2023

Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Inotiv, Inc. Announces Changes to Its Board Composition

Harlan Holdings Ltd. acquired Israeli Businesses from Inotiv, Inc. for $3.7 million.

Harlan Holdings Ltd. acquired Israeli Businesses from Inotiv, Inc. for $3.7 million.

New minor risk - Market cap size

Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Inotiv, Inc. Revises Earnings Guidance for the Full Year 2023

Inotiv, Inc. to Report Q3, 2023 Results on Aug 10, 2023

New minor risk - Share price stability

Price target decreased by 12% to US$15.06

Inotiv, Inc.(NasdaqCM:NOTV) dropped from Russell Small Cap Comp Value Index

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Inotiv, Inc. Confirms Revenue Guidance for the Fiscal Year 2023

Is Inotiv (NASDAQ:NOTV) Using Debt In A Risky Way?

Price target increased by 91% to US$17.17

Inotiv, Inc. Reiterates Financial Guidance for the Fiscal Year Ending September 30, 2023

Inotiv, Inc. Reports Goodwill Impairment Charges for the First Quarter Ended December 31, 2022

Inotiv, Inc. to Report Q1, 2023 Results on Feb 13, 2023

Inotiv, Inc., Annual General Meeting, Mar 16, 2023

Inotiv, Inc. Announces Board Changes

Inotiv, Inc. Provides Revenue Guidance for the First Quarter and Second Quarter to Fourth Quarter and Earnings Guidance for the Full Year Fiscal 2023

Inotiv, Inc. to Report Q4, 2022 Results on Jan 10, 2023

Inotiv, Inc. announced delayed annual 10-K filing

Inotiv, Inc. Provides Revenue Guidance for the Fiscal Year 2022

Inotiv, Inc. Announces Additional Site Consolidation Plan in the U.S

Inotiv, Inc. to Report Q4, 2022 Results on Dec 12, 2022

Price target decreased to US$50.33

Price target decreased to US$50.33

Bronstein, Gewirtz & Grossman, LLC Notifies Investors That A Class Action Lawsuit Has Been Filed Against Inotiv, Inc

Inotiv, Inc. Revises Earnings Guidance for the Fiscal Year Ending September 30, 2022

Law Offices of Howard G. Smith Files Lawsuit Against Inotiv, Inc

Inotiv, Inc. to Report Q3, 2022 Results on Aug 10, 2022

Inotiv, Inc. Decides to Close Two of its Facilities, a Purpose-Bred Canine Facility in Cumberland, Virginia

Inotiv adds 16% on settlement with U.S. over Virginia facility

Inotiv, Inc. (NasdaqCM:NOTV) acquired Protypia, Inc. for $11 million.

Inotiv completes acquisition of bioanalytical company Protypia for ~$11M

Inotiv, Inc. Announces Retirement of James Harkness as Chief Operating Officer, Effective from September 30, 2022

Kirby McInerney LLP Announces Filing of Securities Class Action on Behalf of Inotiv, Inc. Investors

Inotiv, Inc. Appoints Glenn Washer as Group President, Safety Assessment

Price target decreased to US$57.00

Headwaters Capital - Inotiv: Transformation Into A Critical Full-Service Contract Research Organization

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations